Results 1 to 10 of about 15,737 (215)
Exploring the advancements of Australian OPAT
Therapeutic Advances in Infectious Disease, 2023 Outpatient parenteral antimicrobial therapy (OPAT) in Australia has evolved from modest beginnings to a well-established health service with proven benefits in patient outcomes.
Tony Lai +6 more
doaj +3 more sources
A bundle of the top 10 OPAT publications in 2024 [PDF]
Antimicrobial Stewardship & Healthcare EpidemiologyObjective: Outpatient parenteral antimicrobial therapy (OPAT) is a mainstay of clinical infectious diseases practice, and OPAT-related publications continue to be prominent in journals.
Lindsey M. Childs-Kean +9 more
doaj +2 more sources
Management of outpatient parenteral antibiotic therapy: a United States-based multi-center survey [PDF]
Antimicrobial Stewardship & Healthcare EpidemiologyObjective: Outpatient parenteral antimicrobial therapy (OPAT) programs continue to evolve with increases in multidisciplinary teams, complex oral antibiotics, long-acting injectable antimicrobials, patients with substance use disorder (SUD) and ...
Laila M. Castellino +5 more
doaj +2 more sources
Antibiotics, 2022 Outpatient parenteral antimicrobial therapy (OPAT) programs encompass a range of healthcare processes aiming to treat infections at home, with the preferential use of the intravenous route.
Sara Ortonobes +11 more
exaly +3 more sources
AntibioticsOutpatient parenteral antimicrobial therapy (OPAT) aims to deliver intravenous antimicrobials to medically stable patients with complex infections outside of a hospital setting. There is good evidence to demonstrate the safety and efficacy of OPAT in the
Shuchita Soni +5 more
exaly +3 more sources
Antimicrobial Stewardship & Healthcare Epidemiology, 2023 Background: Patients receiving outpatient parenteral antimicrobial therapy (OPAT) are often medically complex and require carefully tailored treatments to address severe and often concomitant infections.
Madison Ponder +5 more
doaj +2 more sources
Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service [PDF]
International Journal of Antimicrobial Agents, 2018 Outpatient parenteral antimicrobial therapy (OPAT) has evolved relatively slowly in the UK. This study describes the OPAT service based in a large UK teaching hospital in Sheffield, and examines the clinical efficacy, patient acceptability and costs saved over a 10-year period. Data on 3812 episodes of OPAT administered between January 2006 and January
Oyewole Christopher Durojaiye
exaly +3 more sources
Clinical outcomes of teicoplanin use in the OPAT setting
International Journal of Antimicrobial Agents, 2020 Teicoplanin possesses several convenient properties for use in the delivery of outpatient parenteral antimicrobial therapy (OPAT) services. However, its use is not widespread and data on its efficacy in the OPAT setting are limited. Here we present a case series of patients undergoing OPAT care being treated by either teicoplanin-based (n = 107) or ...
Jonathan Underwood +2 more
exaly +4 more sources
Antimicrobial Stewardship & Healthcare Epidemiology, 2023 Background: Parkland Health is a 900-bed safety-net hospital that serves Dallas County, Texas. It has an OPAT program in which patients are managed via self-administration (S-OPAT), home-health/hemodialysis (H-OPAT), and skilled nursing facilities (SNF ...
Rory Bouzigard +6 more
doaj +1 more source
Antibiotics, 2022 This nationwide study assessed how outpatient parenteral antimicrobial therapy (OPAT) is organised by Dutch acute care hospitals, the barriers experienced, and how an OPAT program affects the way hospitals organised OPAT care. We systematically developed
Hester H. Stoorvogel +6 more
doaj +1 more source